microdosing semaglutide for perimenopause GLP-1 and Menopause: A Hormone-Aware Metabolic Framework Ozempic 'microdosing' is becoming popular.

Nausea and Vomiting Nausea is the most commonly reported side effect of semaglutide, with around 44% of people using Wegovy, experiencing nausea during clinical trials resulting in 6.8% of patients permanently discontinuing treatment as the result of adverse reactions

While chromium found in food is safe, taking high-dose chromium supplements can lead to side effects like low blood sugar (hypoglycemia) and potential organ damage

Taking semaglutide and tirzepatide together is generally not recommended

Remember that perimenopausal weight management is a marathon, not a sprint, and multiple strategies may be needed to achieve sustainable results whilst supporting overall health during this transitional phase

Our team provides ongoing support to maximize your results

Long-term Use of Semaglutide and Risk of Diabetic Retinopathy Progression